Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Double homeobox protein B (DUXB) is a PRD-like homeobox transcription factor encoded by the human DUXB gene. The DUX family contains several homologous genes with roles in embryonic gene regulation and chromatin remodeling; DUXB has two homeodomains and is predicted to bind DNA and regulate transcription by RNA polymerase II. DUXB is distinct from the related DUX4, which is pathogenic in facioscapulohumeral muscular dystrophy (FSHD); DUXB itself is transcriptionally inactive in most tested assays and is considered to have limited or no transcriptional activation capacity, with unclear biological function and disease relevance. Alternative meanings: There is some ambiguity as "double homeobox" may refer to other DUX family proteins (like DUXA, DUX4), but "DUXB" specifically refers to Double homeobox protein B in humans. No major errors or ambiguities with this target designation were identified.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Double homeobox protein B (DUXB).